Table 1 Patient characteristics at baseline
Silicon carbide-coated BMS | Uncoated cobalt-chromium BMS | P-valuea | |
|---|---|---|---|
No. patients | 761 | 765 | |
Age, y (median, [IQR]) | 63 [55–71] | 64 [57–72] | 0.11 |
Male sex | 570 (74.9) | 586 (76.6) | 0.48 |
Cardiac risk factors | |||
Arterial hypertension | 510 (67.0) | 485 (63.4) | 0.15 |
Hyperlipidemia | 471 (61.9) | 495 (64.7) | 0.28 |
Diabetes mellitus | 141 (18.5) | 108 (14.1) | 0.024 |
Active smoker | 502 (66.0) | 464 (60.7) | 0.036 |
Prior MI | 75 (9.9) | 100 (13.1) | 0.059 |
Prior PCI | 115 (15.1) | 88 (11.5) | 0.046 |
Prior CABG | 14 (1.8) | 20 (2.6) | 0.39 |
Comorbidity | |||
Heart failure | 45 (5.9) | 53 (6.9) | 0.48 |
Prior stroke/TIA | 8 (1.1) | 31 (4.1) | <0.001 |
PAOD | 34 (4.5) | 30 (3.9) | 0.69 |
COPD | 55 (7.2) | 48 (6.3) | 0.52 |
Cancer | 28 (3.7) | 37 (4.8) | 0.32 |
Clinical presentation | |||
Stable angina | 300 (39.4) | 285 (37.3) | 0.41 |
NSTE-ACS | 253 (33.2) | 246 (32.2) | 0.69 |
STEMI | 208 (27.3) | 234 (30.6) | 0.18 |